China In Situ Hybridization Market Size & Outlook

The in situ hybridization market in China is expected to reach a projected revenue of US$ 116.2 million by 2030. A compound annual growth rate of 7.1% is expected of China in situ hybridization market from 2024 to 2030.

Revenue, 2023 (US$M)
$71.8
Forecast, 2030 (US$M)
$116.2
CAGR, 2024 - 2030
7.1%
Report Coverage
China

China in situ hybridization market highlights

  • The China in situ hybridization market generated a revenue of USD 71.8 million in 2023 and is expected to reach USD 116.2 million by 2030.
  • The China market is expected to grow at a CAGR of 7.1% from 2024 to 2030.
  • In terms of segment, fish was the largest revenue generating technology in 2023.
  • CISH is the most lucrative technology segment registering the fastest growth during the forecast period.


In situ hybridization market data book summary

Market revenue in 2023USD 71.8 million
Market revenue in 2030USD 116.2 million
Growth rate7.1% (CAGR from 2023 to 2030)
Largest segmentFish
Fastest growing segmentCISH
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationFISH, CISH
Key market players worldwideThermo Fisher Scientific Inc, Abbott Laboratories, Agilent Technologies Inc, Merck KGaA, Bio-Rad Laboratories Inc, Bio View Ltd, Revvity Inc


Other key industry trends

  • In terms of revenue, China accounted for 4.5% of the global in situ hybridization market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, India in situ hybridization market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 118.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

In Situ Hybridization Market Companies

Name Profile # Employees HQ Website

China in situ hybridization market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in situ hybridization market will help companies and investors design strategic landscapes.


Fish was the largest segment with a revenue share of 53.06% in 2023. Horizon Databook has segmented the China in situ hybridization market based on fish, cish covering the revenue growth of each sub-segment from 2018 to 2030.


Significant investments in the life sciences & healthcare sector and numerous strategic mergers & acquisition activities in the country are expected to boost the market. For instance, according to Pitch Book Data, Inc., in 2021, venture-capital investment in biotechnology startups in China accounted for USD 16.6 billion, with over 568 venture financing events.

Furthermore, in 2020, the country observed 169 merger & acquisition deals in the life sciences and healthcare domain, strengthening the growth of the industry.

These factors are creating growth opportunities for ISH, which is expected to contribute to market growth over the forecast period. Moreover, owing to economic development and growing disposable income, China is expected to be one of the consistently growing markets for ISH.

Reasons to subscribe to China in situ hybridization market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China in situ hybridization market databook

  • Our clientele includes a mix of in situ hybridization market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China in situ hybridization market , including forecasts for subscribers. This country databook contains high-level insights into China in situ hybridization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China in situ hybridization market size, by technology, 2018-2030 (US$M)

China In Situ Hybridization Market Outlook Share, 2023 & 2030 (US$M)

China in situ hybridization market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more